Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
- Advertising -
Veterinary Vaccines Market:
Veterinary vaccines benefit to increase welfare and health of animals, maximize the production of livestock in producing good results without costing a lot of money manner and avert transmission of diseases among animals and also to humans. Efficient animal production and better access to high-quality protein radically increase meat and egg production and give to greater economic outcome or output.
The veterinary vaccines market has seen significant growth over the past few years, due to fear of imminent epidemics that have led to substantial losses particularly in poultry segment. The global animal vaccines market is poised to reach USD 7197.82 Million by 2020 from USD 5507.3 Million in 2015, at a CAGR of 5.5% from 2015 to 2020.
- Advertising -
Browse Full Report @ www.marketdataforecast.com/market-…ccines-market-75/
Veterinary Vaccines Market Overview:
Veterinary vaccine market has shown significant growth in recent years which can be attributed to increasing husbandry practices and better management of farms. This marks the estimation of further growth in the market due to advancement in biotechnological research.
The global veterinary vaccines market has undergone considerable progress during the past few years with the growing usage of continuous cell lines as a substrate and embracing of the fermenter technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics.
Drivers, Restraints, Opportunities, and Challenges Analysis:
- Market Drivers
- Market Restraints
- Key Challenges
- Current Opportunities in the Market
The Global veterinary vaccines market Segmented as livestock and companion vaccines. The livestock vaccines segment has been further segmented into five categories namely, bovine, porcine, ovine, poultry and equine.
The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines.
The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine.
Get Free Sample of this Report @ www.marketdataforecast.com/market-…75/request-sample
Based on geography the global market is analyzed under various regions namely, North America, Europe, Asia Pacific, Latin America and Middle-East & Africa. European region is leading the veterinary vaccine market in terms of consumption, followed by the U.S.
These two regions together account for more than 70% of the global veterinary vaccine market revenue.
Veterinary Vaccines Market Key Players:
8.1 Bayer Healthcare AG
8.2 Bioniche Animal Health Canada
8.3 Sanofi Animal Health Inc.
8.4 Biogenesis Bago SA
8.5 Heska Corporation
8.6 Indian Immunologicals Ltd.
8.7 Boehringer Ingelheim GmbH
8.8 Novartis Animal Health, Inc.
8.9 Merck & Co. Inc.
8.10 Protein Science.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: